European Union · Record · QUESTION_WRITTEN_PRIORITY
P-8-2019-000730
Authorisation of Olaratumab (Lartruvo) in the European Union
Introduced
6 February 2019
Last action
—
Status
QUESTION_WRITTEN_PRIORITY
Sponsors
—
Subjects
Discovery layer
Source updated
6 February 2019
Records
Official record P-8-2019-000730 from European Union at European Parliament. Dated 6 February 2019. Status: QUESTION_WRITTEN_PRIORITY.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
6 official files
Authorisation of Olaratumab (Lartruvo) in the European Union
Authorisation of Olaratumab (Lartruvo) in the European Union
QUESTION_WRITTEN_PRIORITY · EN · 13 February 2019
Authorisation of Olaratumab (Lartruvo) in the European Union
QUESTION_WRITTEN_PRIORITY · EN · 13 February 2019
Authorisation of Olaratumab (Lartruvo) in the European Union
QUESTION_WRITTEN_PRIORITY · EN · 8 February 2019
Authorisation of Olaratumab (Lartruvo) in the European Union
QUESTION_WRITTEN_PRIORITY · EN · 8 February 2019
Authorisation of Olaratumab (Lartruvo) in the European Union
QUESTION_WRITTEN_PRIORITY · EN · 8 February 2019
Answer
QUESTION_WRITTEN_ANSWER
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.